Medications

BioAnalytix advances the biologic drug development

Biologic drugs are highly complex, but they may be the answer to many medical illnesses and conditions that currently have no treatment available. The problem is, these drugs are not easy to characterize and test. Unlike ...

Jun 11, 2014
popularity 2 / 5 (1) | comments 0

Challenges to equitable access to medicines

(Medical Xpress)—Access to medicines by vulnerable groups in the community, increasing medicine costs, and the demand for new medicines are some of the challenges identified in an independent study of priority medicine ...

Jun 11, 2014
popularity not rated yet | comments 0

Federal views diverge on proper use of painkillers

How do you have a conversation about prescription drugs that provide critical pain relief to millions of Americans yet also cause more fatal overdoses than heroin and cocaine combined? The answer is: It depends.

Jun 10, 2014
popularity 2.5 / 5 (2) | comments 1

Merck to pay $3.85B for hepatitis C drug developer

Merck & Co. will spend about $3.85 billion for Idenix Pharmaceuticals Inc., a small company developing hepatitis C medicines that, together with Merck's experimental drugs, could produce lucrative combo therapies ...

Jun 09, 2014
popularity not rated yet | comments 0

Toward a better drug against malaria

A research team led by Prof. Dr. Carola Hunte has succeeded in describing how the antimalarial drug atovaquone binds to its target protein. The scientists used x-ray crystallography to determine the three-dimensional ...

Jun 06, 2014
popularity not rated yet | comments 0